# Contrast Media Market

> 콘트라스트 미디어 시장 조사 보고서 - 2032년까지의 글로벌 전망

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.76%
- **2024:** $ 6.74 Billion
- **2025:** $ 7.06 Billion
- **2035:** $ 11.24 Billion
- **Key Players:** Companies such as Bayer AG (DE), GE Healthcare (US), Bristol-Myers Squibb Company (US), Bracco Imaging S.p.A. (IT), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), Canon Medical Systems Corporation (JP), Hoffmann-La Roche Ltd (CH) are some of the major participants in the global market.

**Report ID:** MRFR/LS/0776-HCR · **Pages:** 90 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 11, 2026

**URL:** https://www.marketresearchfuture.com/reports/contrast-media-market-1284

---

## Market Summary

According to Market Research Future analysis, the Contrast Media Market Size was valued at USD 6.74 Billion in 2024 & the market is projected to grow from USD 7.061 Billion in 2025 to USD 11.24 Billion by 2035, registering a CAGR of 4.76% during the forecast period 2025–2035. North America led the market with over 45% share, generating around USD 3.03 billion in revenue. Rising prevalence of chronic diseases and increasing demand for advanced diagnostic imaging procedures are key growth drivers for the contrast media market. Expanding healthcare infrastructure and technological advancements in imaging modalities further accelerate adoption of contrast agents globally.

- According to WHO, cardiovascular diseases cause 17.9 million deaths annually, while cancer accounts for nearly 10 million deaths globally — together representing the world's leading causes of death and significantly increasing diagnostic imaging demand. OECD Health Statistics show diagnostic imaging procedures, including CT scans, have risen substantially over the past decade across member countries, with exam volumes growing faster than scanner availability in most nations — a trend supporting continued growth in contrast media utilization worldwide. (Source: [WHO — Cardiovascular diseases](https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1))

## Market Drivers

### Rising Incidence of Chronic Diseases

암, 심혈관 질환, 신경 질환과 같은 만성 질환의 유병률 증가는 조영제 시장의 주요 동인입니다. 이러한 질병은 진단과 모니터링을 위해 첨단 영상기술이 필요하기 때문에 조영제에 대한 수요는 더욱 늘어날 것으로 예상됩니다.
 
최근 통계에 따르면 암 발병률이 증가할 것으로 예상되며, 이로 인해 조영제를 활용하는 MRI, CT 스캔과 같은 영상 기법에 대한 필요성이 높아질 것으로 예상됩니다. 이러한 추세는 의료 서비스 제공자가 정확한 진단 및 치료 계획을 위한 효과적인 솔루션을 추구함에 따라 조영제 시장이 성장하고 있음을 나타냅니다. 더욱이, 인구 고령화로 인해 이러한 추세가 더욱 악화될 가능성이 있습니다. 노인들이 만성 질환에 더 취약해 의료 영상에서 조영제에 대한 수요가 더욱 촉진될 가능성이 있기 때문입니다.

### Increase in Diagnostic Imaging Procedures

진단 영상 절차의 증가는 조영제 시장의 중요한 동인입니다. 의료 시스템이 정확한 진단을 위해 점점 더 영상화에 의존함에 따라 조영제에 대한 수요가 증가할 가능성이 높습니다. 보고서에 따르면 매년 수행되는 CT 및 MRI 스캔 수가 급증했으며 이는 보다 포괄적인 진단 접근 방식으로의 전환을 반영합니다.
 
이러한 증가는 조기 질병 발견의 중요성에 대한 인식이 높아지고 이러한 절차를 용이하게 하는 영상 기술의 발전에 기인합니다. 결과적으로, 의료 서비스 제공자가 고품질 조영제 사용을 통해 영상 연구의 효율성을 향상시키려고 함에 따라 시장은 성장할 준비가 되어 있습니다. 이러한 추세는 현대 진단 관행에서 조영제의 필수적인 역할을 강조합니다.

### Growing Awareness of Preventive Healthcare

예방 의료에 대한 강조가 증가함에 따라 진단 영상에 대한 수요가 증가하여 조영제 시장에 영향을 미치고 있습니다. 환자와 의료 서비스 제공자가 조기 발견 및 개입의 중요성을 인식함에 따라 조영제가 필요한 영상 기술의 활용이 높아질 가능성이 높습니다.
 
교육 캠페인과 공중 보건 이니셔티브는 예방 치료 문화를 조성하여 고급 영상 촬영이 포함된 정기 건강 검진을 원하는 개인이 늘어나고 있습니다. 이러한 추세는 영상 연구의 품질을 향상시키는 데 중요한 역할을 하기 때문에 조영제에 대한 수요를 증가시킬 것으로 예상됩니다. 결과적으로 시장은 조기 진단과 치료를 우선시하는 예방 의료 관행으로의 광범위한 변화에 맞춰 성장할 수 있는 위치에 있습니다.

### Technological Innovations in Imaging Techniques

이미징 방식의 기술 발전은 조영제 시장에 큰 영향을 미치고 있습니다. 3D 이미징, 하이브리드 이미징 시스템, 향상된 MRI 기술과 같은 혁신으로 인해 고급 조영제의 채택이 촉진되고 있습니다. 이러한 기술은 진단 정확도와 환자 결과를 향상시켜 조영제 활용도를 높입니다.
 
예를 들어,[가돌리늄](https://www.marketresearchfuture.com/reports/gadolinium-market-21692)기반 조영제는 MRI 영상에 혁명을 일으켜 더 선명한 이미지와 더 나은 진단 기능을 제공합니다. 의료 시설이 영상 품질을 향상시키기 위해 정교한 조영제가 필요한 최첨단 영상 기술에 투자함에 따라 조영제 시장은 확대될 것으로 예상됩니다. 이러한 추세는 발전하는 의료 영상 환경에 적응하면서 조영제 부문의 강력한 성장 궤적을 시사합니다.

### Regulatory Support for Advanced Imaging Solutions

규제 기관은 점점 더 고급 이미징 솔루션의 개발 및 승인을 지원하고 있으며 이는 조영제 시장에 긍정적인 영향을 미치고 있습니다. 새로운 조영제 및 이미징 기술에 대한 승인 프로세스를 가속화하기 위한 계획은 혁신을 촉진하고 시장 성장을 강화할 가능성이 높습니다. 예를 들어, 규제 기관은 새로운 조영제에 대한 더 빠른 접근을 촉진하는 프레임워크를 도입하여 의료 서비스 제공자가 이미징의 최신 발전을 활용할 수 있도록 보장했습니다.
 
이러한 규제 지원은 연구 개발을 장려할 뿐만 아니라 최첨단 진단 도구에 대한 환자의 접근성을 향상시킵니다. 결과적으로 시장은 더욱 유리한 규제 환경의 혜택을 누리고 의료 전문가의 진화하는 요구를 충족하는 혁신적인 제품의 도입을 촉진할 것으로 예상됩니다.

## Future Outlook

The Contrast Media Market size is projected to reach USD 11.24 Billion by 2035, growing at a CAGR of 4.76%, driven by technological advancements, increasing diagnostic imaging demand, and rising healthcare expenditures.

**New opportunities:**

- Development of AI-driven imaging solutions for enhanced diagnostic accuracy. Expansion into emerging markets with tailored contrast media products. Partnerships with healthcare providers for integrated imaging services.

By 2035, the Contrast Media Market is expected to achieve robust growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type: Iodinated Contrast Media (Largest) vs. Gadolinium-Based Contrast Media (Fastest-Growing)

The market is predominantly supported by iodinated contrast media, which consistently hold the largest share in the Contrast Media Market at 62% within the segment. This type accounts for a significant portion of the diagnostic imaging procedures, preferred for its effectiveness in enhancing the contrast of imaging results. In contrast, Gadolinium-Based Contrast Media, while smaller in share compared to Iodinated types, is witnessing a rapid increase in acceptance due to its favorable safety profile, particularly among patients with renal issues.

Contrast Media: Iodinated Contrast Media (Dominant) vs. Gadolinium-Based Contrast Media (Emerging)

Iodinated Contrast Media is widely regarded as the dominant type due to its extensive application in various imaging modalities, including X-rays and CT scans. Its high osmolarity offers enhanced visualization, which makes it a staple choice in clinical settings. On the other hand, Gadolinium-Based Contrast Media is emerging rapidly as a preferred alternative, especially in MRI procedures. It is known for its reduced risk of adverse reactions, making it highly appealing, particularly in patients with renal impairment. The increasing awareness and adoption of gadolinium media are driven by ongoing research showcasing its efficacy and safety, thereby augmenting its market growth.

### By Form: Liquid (Largest) vs. Tablet (Fastest-Growing)

In the Contrast Media Market, liquid forms dominate the market, holding a 78% share due to their widespread applicability and effectiveness in imaging procedures. These products continue to be the preferred choice for many medical professionals because of their ease of administration and rapid action within the body. Tablets, while currently a smaller segment, are rapidly gaining traction as they offer convenience and improved patient compliance, positioning themselves as a viable alternative to traditional liquid forms.

Liquid (Dominant) vs. Tablet (Emerging)

Liquid contrast media is recognized for its superior efficacy in enhancing imaging results, with a broad range of applications in various diagnostic imaging modalities such as X-rays and CT scans. Its extensive utilization in hospitals fortifies its position as the dominant form in the market. On the other hand, tablet contrast media is emerging as a convenient option, particularly for patients who prefer an oral intake method. Its growth is propelled by advancements in formulation technology that enhance absorption and bioavailability, making it an appealing choice for both patients and healthcare providers.

### By Procedure: X-ray/CT (Largest) vs. MRI (Fastest-Growing)

X-ray/Computed Tomography (CT) holds the largest share in the Contrast Media Market at 64%, representing a significant portion of overall usage. This dominance is attributed to the widespread application of X-ray and CT imaging in various diagnostic procedures, making it a preferred choice among healthcare professionals. Meanwhile, Magnetic Resonance Imaging (MRI) is rapidly gaining traction, driven by its non-invasive nature and superior soft tissue contrast, appealing to an increasing number of clinicians and patients alike.

Imaging Technologies: X-ray/CT (Dominant) vs. MRI (Emerging)

X-ray/CT technology is well-established in the medical imaging field, known for its quick diagnostic capabilities and ongoing integration with digital technologies, which enhance image quality and patient safety. On the other hand, MRI is viewed as an emerging player in the market, particularly favored for its ability to provide detailed images of soft tissues without radiation. The increasing prevalence of chronic diseases necessitating precise imaging and the advancement of MRI technology are key drivers propelling its growth. As practitioners seek out improved diagnostic methods, MRI is poised to capture greater market share in the upcoming years, complementing the already dominant X-ray/CT segment.

### By Application: Cardiovascular Disease (Largest) vs. Oncology (Fastest-Growing)

In the Contrast Media Market, the application segment is prominently led by cardiovascular disease applications, which represent the largest share at 36%. This segment benefits from the increasing prevalence of heart-related ailments, driving demand for effective diagnostic solutions. Additionally, oncology applications are witnessing accelerated growth, spurred by rising cancer incidences and innovative advancements in imaging techniques to enhance tumor detection and monitoring. As a result, the applications of contrast media in these areas capture significant market attention.

Cardiovascular Disease (Dominant) vs. Oncology (Emerging)

The cardiovascular disease segment remains dominant within the contrast media applications, aided by its extensive use in diagnostic imaging modalities that significantly improve patient outcomes. Cardiovascular procedures that utilize contrast media enhance visualization of the heart and blood vessels, which are crucial for accurate diagnosis and treatment planning. Conversely, the oncology segment is emerging rapidly, fueled by innovations in imaging technologies and targeted therapeutics. The increasing focus on early detection of cancers through advanced imaging methods highlights the growing adoption of contrast media, positioning it as a pivotal application in comprehensive cancer care.

## Regional Market Share Analysis

### 북미 : 혁신과 수요를 선도

북미는 조영제 시장 규모에서 선두를 달리고 있으며 2024년 전 세계 매출의 45% 이상을 차지했습니다. 이 지역의 성장은 첨단 의료 인프라, 만성 질환의 유병률 증가, 진단 영상에 대한 수요 증가에 의해 주도됩니다. FDA와 같은 기관의 규제 지원은 시장 확장을 더욱 촉진하여 조영제 제품의 안전성과 효능을 보장합니다.

- CDC는 1억 2,900만 명 이상의 미국인이 적어도 하나의 만성 질환을 앓고 있으며, 미국에서 영상 촬영 절차가 연간 8,000만 건을 초과한다고 보고합니다. 이러한 높은 진단량은 병원과 진단 센터 전체에서 조영제 수요를 크게 증가시킵니다. (원천:[CDC / 만성 질환 예방 — 미국의 만성 질환 유병률](https://www.cdc.gov/pcd/issues/2024/23_0267.htm))

미국은 의료 기술과 연구에 상당한 투자를 하는 주요 기여국입니다. GE Healthcare 및 Bristol-Myers Squibb과 같은 주요 기업은 혁신적인 솔루션과 파트너십에 중점을 두고 이 시장에서 두각을 나타내고 있습니다. 경쟁 환경은 이미징 기술의 지속적인 발전, 환자 결과 향상 및 시장 성장 촉진을 특징으로 합니다.

### 유럽: 규제 체계 및 성장

유럽 ​​조영제 시장 규모는 2024년 기준 20억 2천만 달러로 평가되어 30% 점유율로 두 번째로 큰 지역 시장이 되었습니다. 이 지역은 의료 제품의 고품질 표준을 보장하는 엄격한 규제 체계의 혜택을 받고 있습니다. 의료 인프라에 대한 투자 증가와 인구 노령화 증가가 수요의 주요 동인입니다.

- WHO 유럽에 따르면 인구의 약 25%가 60세 이상이며, 만성질환으로 인한 사망자가 86% 이상입니다. 또한 EU 국가 전체에서 영상 활용도가 약 18% 증가하여 조영제 수요 증가를 뒷받침했습니다.

독일, 프랑스 등의 국가는 유리한 상환 정책과 기술 발전을 바탕으로 시장을 선도하고 있습니다. 독일은 Bayer AG 및 Siemens Healthineers와 같은 기업의 상당한 기여를 통해 주요 국가로 두각을 나타내고 있습니다. 핵심 기업 간의 혁신과 협력에 중점을 두고 경쟁 환경이 견고합니다. 유럽 ​​시장에서도 고급 이미징 기술의 채택이 증가하고 있으며, 이는 조영제 부문의 성장을 더욱 촉진하고 있습니다.

### 아시아 태평양: 신흥 시장 잠재력

아시아 태평양 지역은 조영제 시장에서 신흥 강자로 전 세계 점유율의 약 20%를 차지합니다. 의료비 지출 증가, 진단 영상에 대한 인식 증가, 환자 인구 증가로 인해 이 지역의 성장이 가속화되고 있습니다. 중국과 인도 같은 국가는 의료 인프라와 기술에 막대한 투자를 하며 선두에 있습니다.

규제 기관은 또한 시장 성장을 지원하기 위해 프레임워크를 강화하고 있습니다. 중국은 고급 이미징 기술에 대한 수요 급증으로 인해 이 지역에서 가장 큰 시장입니다. Fujifilm Holdings 및 Canon Medical Systems와 같은 주요 업체는 현지 요구에 맞는 혁신적인 제품에 중점을 두고 입지를 확대하고 있습니다. 빠르게 성장하는 이 부문의 시장 점유율이 혼합되면서 경쟁 환경이 진화하고 있습니다.

### 중동 및 아프리카: 아직 개척되지 않은 시장 기회

중동 및 아프리카 지역은 성장하는 조영제 시장을 대표하며 전 세계 점유율의 약 5%를 차지합니다. 이러한 성장은 의료 투자 증가, 진단 영상에 대한 인식 증가, 인구 증가에 의해 주도됩니다. 남아프리카 공화국 및 UAE와 같은 국가는 의료 접근성과 품질을 향상시키기 위한 정부 이니셔티브의 지원을 받아 시장을 선도하고 있습니다.

남아프리카공화국은 의료 인프라와 기술 향상에 중점을 두고 있는 핵심 국가입니다. 경쟁 환경에는 현지 기업과 국제 기업이 모두 포함되며 파트너십과 협업이 점점 더 강조되고 있습니다. 지역이 계속 발전함에 따라 고급 이미징 솔루션에 대한 수요가 증가할 것으로 예상되며 이는 시장 참여자에게 상당한 기회를 제공할 것입니다.

## Competitive Benchmarking

The Contrast Media Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diagnostic imaging. Key players such as Bayer AG (Germany), GE Healthcare (US), and Bracco Imaging S.p.A. (Italy) are at the forefront, each adopting distinct strategies to enhance their market presence.
 
Bayer AG (Germany) focuses on innovation in contrast agents, particularly in the development of safer and more effective products, while GE Healthcare (US) emphasizes digital transformation and integration of AI in imaging technologies. Bracco Imaging S.p.A. (Italy) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing healthcare infrastructure. Collectively, these strategies not only enhance their competitive positioning but also contribute to a more robust market environment. 
 
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure fosters an environment where smaller firms can thrive by focusing on niche markets or specialized products, thereby enhancing overall market dynamism. 
 
In August 2025, Bayer AG (Germany) announced a strategic partnership with a leading AI technology firm to develop advanced imaging solutions that enhance diagnostic accuracy. This collaboration is poised to leverage AI capabilities to improve the efficacy of contrast media, potentially revolutionizing patient outcomes in diagnostic imaging. The strategic importance of this partnership lies in its potential to position Bayer as a leader in the integration of AI within the contrast media sector, aligning with broader industry trends towards digitalization. 
 
In September 2025, GE Healthcare (US) launched a new line of contrast agents designed specifically for pediatric patients, addressing a critical gap in the market. This initiative not only demonstrates GE's commitment to patient safety but also reflects a growing trend towards personalized medicine. By focusing on the unique needs of pediatric patients, GE Healthcare is likely to enhance its market share and strengthen its brand loyalty among healthcare providers. 
 
In July 2025, Bracco Imaging S.p.A. (Italy) expanded its operations in Asia by establishing a new manufacturing facility in India. This move is strategically significant as it allows Bracco to tap into the rapidly growing healthcare market in the region, while also optimizing its supply chain. The establishment of local manufacturing capabilities is expected to reduce lead times and costs, thereby enhancing Bracco's competitive edge in the Asian market. 
 
As of October 2025, the Contrast Media Market is witnessing trends such as increased digitalization, sustainability initiatives, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. Companies that prioritize innovation and adapt to evolving market demands are likely to emerge as leaders in this rapidly changing environment.

## Recent News & Developments

**October 2022: **G.E. Healthcare's pharmaceutical diagnostics company announced a long-term agreement with the Chilean mining company Sociedad Quimica y Minera (SQM) de Chile S.A. to guarantee its supply of iodine, which is used in X-ray contrast media products. Vital components and computed tomography procedures around the world. As part of G.E. Healthcare's larger commitment and investment plan, this will help SQM expand its supply of iodine raw material year-on-year, producing an additional 30 Billion doses of iodine contrast media per year by 2025.

**December 2021: **The previously announced G.E. Healthcare acquisition of B.K. Medical was finalized. With this acquisition, G.E. Healthcare has enhanced its pre- and post-operative ultrasound capabilities to cover real-time surgical observation, a fast-growing and relatively new discipline.

## Report Scope

| MARKET SIZE 2024 | 6.74(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 7.061(USD Billion) |
| MARKET SIZE 2035 | 11.24(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.76% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Bayer AG (DE), GE Healthcare (US), Bristol-Myers Squibb Company (US), Bracco Imaging S.p.A. (IT), Fujifilm Holdings Corporation (JP), Siemens Healthineers (DE), Canon Medical Systems Corporation (JP), Hoffmann-La Roche Ltd (CH) |
| Segments Covered | Type, Form, Procedures, Application, Region |
| Key Market Opportunities | Advancements in artificial intelligence enhance diagnostic accuracy in the market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Contrast Media Market as of 2024?**
A: The Contrast Media Market was valued at 6.74 USD Billion in 2024.

**Q: What is the projected market valuation for the Contrast Media Market in 2035?**
A: The market is projected to reach 11.24 USD Billion by 2035.

**Q: What is the expected CAGR for the market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during 2025 - 2035 is 4.76%.

**Q: Which segment of the Contrast Media Market is expected to grow the most by 2035?**
A: Iodinated Contrast Media is anticipated to grow from 4.04 USD Billion in 2024 to 6.7 USD Billion by 2035.

**Q: How do Gadolinium-Based Contrast Media valuations compare between 2024 and 2035?**
A: Gadolinium-Based Contrast Media is expected to increase from 2.7 USD Billion in 2024 to 4.54 USD Billion by 2035.

**Q: What forms of contrast media are projected to see significant growth by 2035?**
A: Liquid forms are expected to grow from 2.68 USD Billion in 2024 to 4.45 USD Billion by 2035.

**Q: Which medical procedures are driving the demand for contrast media?**
A: X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are key procedures, with CT expected to grow from 3.5 USD Billion in 2024 to 5.8 USD Billion by 2035.

**Q: What applications are contributing to the growth of the Contrast Media Market?**
A: Oncology is projected to grow from 2.68 USD Billion in 2024 to 4.4 USD Billion by 2035, indicating a strong demand in this area.

**Q: Who are the key players in the Contrast Media Market?**
A: Key players include Bayer AG, GE Healthcare, and Bracco Imaging S.p.A., among others.

**Q: What is the expected growth trend for the market in the coming years?**
A: The market is likely to experience steady growth, driven by advancements in imaging technologies and increasing applications in various medical fields.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/contrast-media-market-1284*